Cognition Therapeutics Elucidates Genetic Mutation that Protects Against Alzheimer’s Disease
October 19, 2020 08:00 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
FDA Granted Pediatric Disease Designation for OXi-4503
September 16, 2020 07:00 ET
|
Mateon Therapeutics, Inc.
-Treatment of acute myeloid leukemia (AML) due to genetic mutations that disproportionately affect pediatric patients AGOURA HILLS, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics...
SNS FiRe Conference Names Metabolon Inc. a 2016 FiReStarter Company
September 01, 2016 10:00 ET
|
Strategic News Service
SEATTLE, WA--(Marketwired - September 01, 2016) - Strategic News Service (SNS) has selected Metabolon Inc., the global leader in metabolomics, as a 2016 FiReStarter company to be featured at the 14th...